Stock Region Watchlist
🚀 Stock Region Watchlist: Big Moves & Bold Predictions! Your Daily Dose of Market Insights.
🚀 Stock Region Watchlist: Big Moves & Bold Predictions! Your Daily Dose of Market Insights
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: Hey there, Stock Region readers! Before we dive into this week’s watchlist, let’s get one thing straight: this newsletter is for informational purposes only. We’re not financial advisors, and this isn’t investment advice. Always do your own research and consult a professional before making any financial decisions. Now, let’s talk stocks!
Hello, Stock Region family!
It’s Tuesday, July 22, 2025, and wow, what a week it’s been! The market has been buzzing with drama, comebacks, and some jaw-dropping moves. Let’s break it all down together, shall we?
Opendoor Technologies (OPEN)
🚀 Massive Stock Rally:
Opendoor is the talk of the town! The stock skyrocketed a mind-blowing 189% last week, fueled by retail investors and social media hype. Hedge fund manager Eric Jackson even compared Opendoor’s potential to Carvana’s epic recovery. (Remember Carvana? What a wild ride that was!)
🔥 Meme Stock Momentum:
Reddit’s WallStreetBets is at it again, with users rallying behind Opendoor. It’s like déjà vu from the GameStop days, but this time, it’s all about real estate tech.
💡 Turnaround Potential:
Eric Jackson is calling it: positive EBITDA next month and a long-term price target of $82 per share. Bold, right? But hey, stranger things have happened in this market.
📈 Nasdaq Compliance:
Good news: Opendoor avoided delisting thanks to the recent rally. Keep an eye on these levels:
Upside: Above $4.71
Downside: Below $3.65
Our Take:
Opendoor feels like a high-stakes poker game right now. If you’re in, buckle up—it’s going to be a bumpy (but potentially rewarding) ride.
General Motors ($GM)
📊 Market Share Growth:
GM is flexing its muscles, increasing its U.S. market share to 17.4% in Q2 2025. That’s a solid 0.7% year-over-year gain.
âš¡ EV Expansion:
Electric is the future, and GM knows it. EV sales jumped 111% year-over-year, and Cadillac is now the top-selling U.S. luxury EV brand. (Who else is picturing sleek Cadillacs cruising silently down the highway?)
💪 Resilience Amid Tariffs:
Despite a hefty $1.1 billion in tariff costs, GM is holding strong and sticking to its full-year guidance. That’s some serious grit.
🚗 Strong Deliveries:
With 1.54 million vehicles delivered globally in Q2, GM is proving it’s still a powerhouse. Watch these levels:
Upside: Above $53.39
Downside: Below $51.82
Our Take:
GM is like that friend who always has a plan, no matter what life throws at them. Between EV growth and market share gains, they’re playing the long game—and it’s paying off.
Lockheed Martin ($LMT)
📉 Mixed Q2 Results:
Lockheed’s Q2 was a mixed bag. Revenue hit $18.2 billion, but EPS took a nosedive to $1.46 due to $1.6 billion in program losses. Ouch.
🚀 Positive Developments:
On the bright side, Lockheed secured new F-35 orders, over $1 billion in missile contracts, and satellite orders from the U.S. Space Force. (Space Force! How cool is that?)
💡 Strategic Investments:
The company is investing in the future, pouring $800 million into infrastructure and innovation. Plus, they returned $1.3 billion to shareholders.
📉 Stock Pressure:
Shares dropped nearly 8% after the earnings report. Investors are clearly spooked by those program losses. Key levels to watch:
Upside: Above $431.00
Downside: Below $420.21
Our Take:
Lockheed is like a rollercoaster right now—some thrilling highs, but also some stomach-churning drops. If you’re in it for the long haul, the innovation and contracts could pay off big time.
Medpace ($MEDP)
💥 Strong Q2 Performance:
Medpace crushed it in Q2, with EPS of $3.10 (vs. $2.98 expected) and revenue of $603.31 million (vs. $538.77 million expected). That’s a 14.2% year-over-year increase.
📈 Raised 2025 Guidance:
The company upped its 2025 revenue forecast to $2.42-$2.52 billion and EPS to $13.76-$14.53. Wall Street is loving it.
🚀 Stock Surge:
Medpace’s stock soared 44.39% in pre-market trading. Talk about a confidence boost!
🌱 Growth:
Strategic acquisitions and strong financials are driving Medpace’s success. Levels to watch:
Downside: Below $440.00
Our Take:
Medpace is on fire! If you’re looking for a growth story with solid fundamentals, this one’s worth a closer look.
That’s a wrap for this week!
What do you think of these stocks? Are you bullish, bearish, or just along for the ride? Hit reply and let us know—we’d love to hear from you!
Until next time,
The Stock Region Team
Final Disclaimer: Remember, folks, the stock market is unpredictable, and past performance doesn’t guarantee future results. Always invest responsibly and within your means.